08:05 EDT Grace Therapeutics (GRCE) files to sell 8.84M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRCE:
- Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating
- Grace Therapeutics reports Q3 EPS (36c), consensus (46c)
- Grace Therapeutics price target raised to $11 from $8 at Craig-Hallum
- Grace Therapeutics announces private placement financing of up to $30M
- Grace Therapeutics announces results from Phase 3 STRIVE-ON trial